14-day Premium Trial Subscription Sign Up For FreeGet Free

No Pain, No Gain.Week 21 On Stock Market Click to watch.

Ascendis Pharma A/S Stock Forecast

NASDAQ:ASND BUY SELL

$97.01 (1.69%)

Volume: 573.274k

Closed: May 23, 2022

Hollow Logo Score: 0.496

Ascendis Pharma A/S Stock Forecast

BUY SELL NASDAQ:ASND
$97.01 (1.69%)

Volume: 573.274k

Closed: May 23, 2022

Score Hollow Logo 0.496

Ascendis Pharma A/S Stock Forecast NASDAQ:ASND

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-05-12 26.79% Credit Suisse $194.00 $123.00 Maintains Outperform
2022-05-12 79.36% SVB Leerink $193.00 $174.00 Maintains Outperform
2022-05-12 81.42% Wells Fargo $190.00 $176.00 Maintains Overweight
2022-05-12 62.87% Citigroup $187.00 $158.00 Maintains Buy
2022-03-15 65.96% B of A Securities $148.00 $161.00 Upgrades Neutral Buy
2022-03-15 103.07% Morgan Stanley $180.00 $197.00 Maintains Overweight
2022-03-15 98.95% SVB Leerink $190.00 $193.00 Maintains Outperform
2022-03-14 99.98% Credit Suisse $188.00 $194.00 Maintains Outperform
2022-03-07 85.55% Morgan Stanley $197.00 $180.00 Maintains Overweight
2022-03-03 75.24% Wells Fargo $176.00 $170.00 Maintains Overweight
2022-03-03 20.61% Wedbush $128.00 $117.00 Maintains Outperform
2022-03-03 93.79% Credit Suisse $196.00 $188.00 Maintains Outperform
2022-03-01 92.76% Citigroup $187.00 Initiates Coverage On Buy
2022-02-14 75.24% Oppenheimer $170.00 Upgrades Perform Outperform
2022-01-06 40.19% Cowen & Co. $136.00 Initiates Coverage On Market Perform
2021-12-08 81.42% Wells Fargo $176.00 Initiates Coverage On Overweight
2021-11-15 95.86% SVB Leerink $182.00 $190.00 Maintains Outperform
2021-11-11 84.52% Credit Suisse $185.00 $179.00 Maintains Outperform
2021-10-20 74.21% B of A Securities $164.00 $169.00 Downgrades Buy Neutral
2021-08-26 87.61% SVB Leerink $178.00 $182.00 Maintains Outperform
2021-08-26 110.29% Morgan Stanley $197.00 $204.00 Maintains Overweight
2021-08-26 90.7% Credit Suisse $178.00 $185.00 Maintains Outperform
2021-07-21 83.49% SVB Leerink $181.00 $178.00 Maintains Outperform
2021-06-14 103.07% Morgan Stanley $201.00 $197.00 Maintains Overweight
2021-06-14 94.83% Wedbush $219.00 $189.00 Maintains Outperform
2021-06-14 86.58% SVB Leerink $191.00 $181.00 Maintains Outperform
2021-06-01 102.04% Canaccord Genuity $190.00 $196.00 Maintains Buy
2021-05-28 83.49% Credit Suisse $176.00 $178.00 Maintains Outperform
2021-05-28 107.2% Morgan Stanley $199.00 $201.00 Maintains Overweight
2021-03-30 - Oppenheimer - Downgrades Outperform Perform
2021-03-12 95.86% Canaccord Genuity $172.00 $190.00 Maintains Buy
2021-03-11 81.42% Credit Suisse $178.00 $176.00 Maintains Outperform
2020-12-17 122.66% Berenberg $216.00 Initiates Coverage On Buy
2020-11-13 105.13% Morgan Stanley $194.00 $199.00 Maintains Overweight
2020-11-12 83.49% Credit Suisse $158.00 $178.00 Maintains Outperform
2020-11-12 96.89% SVB Leerink $173.00 $191.00 Maintains Outperform
2020-10-13 99.98% Morgan Stanley $179.00 $194.00 Maintains Overweight
2020-08-31 84.52% Morgan Stanley $177.00 $179.00 Maintains Overweight
2020-08-28 62.87% Credit Suisse $154.00 $158.00 Maintains Outperform
2020-07-15 82.46% Morgan Stanley $181.00 $177.00 Maintains Overweight
2020-05-21 86.58% Morgan Stanley $180.00 $181.00 Maintains Overweight
2020-05-20 114.41% Oppenheimer $219.00 $208.00 Maintains Outperform
2020-05-20 78.33% SVB Leerink $170.00 $173.00 Maintains Outperform
2020-05-20 58.75% Credit Suisse $149.00 $154.00 Maintains Outperform
2020-04-20 75.24% SVB Leerink $152.00 $170.00 Maintains Outperform
2020-04-20 107.2% Cantor Fitzgerald $185.00 $201.00 Reiterates Overweight
2020-04-20 125.75% Oppenheimer $199.00 $219.00 Maintains Outperform
2020-04-20 76.27% Stifel $146.00 $171.00 Maintains Buy
2020-04-20 53.59% Credit Suisse $139.00 $149.00 Maintains Outperform
2020-04-02 85.55% Morgan Stanley $181.00 $180.00 Maintains Overweight
2020-03-20 105.13% Oppenheimer $199.00 Initiates Coverage On Outperform
2020-02-26 86.58% Morgan Stanley $148.00 $181.00 Maintains Overweight
2020-01-17 52.56% Morgan Stanley $140.00 $148.00 Maintains Overweight
2019-12-17 44.32% Morgan Stanley $134.00 $140.00 Maintains Overweight
2019-11-20 38.13% Morgan Stanley $128.00 $134.00 Maintains Overweight
2019-10-22 91.73% Wedbush $191.00 $186.00 Maintains Outperform
2019-10-11 31.95% Morgan Stanley $128.00 Initiates Coverage On Overweight
2019-08-29 56.68% JP Morgan $143.00 $152.00 Maintains Overweight
2019-06-03 129.87% Wedbush $219.00 $223.00 Maintains Outperform
2019-05-31 48.44% Canaccord Genuity $133.00 $144.00 Maintains Buy

ASND Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -20.69% during the next 3 months and, with a 90% probability hold a price between $59.10 and $82.63 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2022-05-25 $74.07 $88.91 $103.74
2022-05-26 $73.63 $88.46 $103.30
2022-05-27 $73.18 $88.02 $102.85
2022-05-31 $72.73 $87.57 $102.40
2022-06-01 $72.29 $87.12 $101.96
2022-06-02 $71.84 $86.68 $101.51
2022-06-03 $71.40 $86.23 $101.07
2022-06-06 $70.95 $85.79 $100.62
2022-06-07 $70.51 $85.34 $100.18
2022-06-08 $70.06 $84.90 $99.73
2022-06-09 $69.62 $84.45 $99.29
2022-06-10 $69.17 $84.01 $98.84
2022-06-13 $68.73 $83.56 $98.40
2022-06-14 $68.28 $83.12 $97.95
2022-06-15 $67.84 $82.67 $97.50
2022-06-16 $67.39 $82.22 $97.06
2022-06-17 $66.94 $81.78 $96.61
2022-06-21 $66.50 $81.33 $96.17
2022-06-22 $66.05 $80.89 $95.72
2022-06-23 $65.61 $80.44 $95.28
2022-06-24 $65.16 $80.00 $94.83
2022-06-27 $64.72 $79.55 $94.39
2022-06-28 $64.27 $79.11 $93.94
2022-06-29 $63.83 $78.66 $93.50
2022-06-30 $63.38 $78.22 $93.05
2022-07-01 $62.94 $77.77 $92.61
2022-07-05 $62.49 $77.32 $92.16
2022-07-06 $62.04 $76.88 $91.71
2022-07-07 $61.60 $76.43 $91.27
2022-07-08 $61.15 $75.99 $90.82

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a clinical stage biopharmaceutical company, develops various prodrug therapies to treat unmet medical needs. It is developing TransCon human growth hormone that has completed Phase II clinical trials in children and adults to treat growth hormone deficiency (GHD) and other indications; and TransCon Treprostinil that has completed Phase I clinical trial for the treatment of pulmonary arterial hypertension, a life-threatening d... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT